ArminLabs (Augsburg, Germany) is CAP and DAkkS (ISO 15189) accredited and CLIA certified. Annual independent assessment, daily quality controls, certified external proficiency programmes (INSTAND, RfB, ESfEQA, CAP), positives repeated. No in-house lab-developed assays anywhere in the catalog; positive and negative thresholds are externally established and validated.
sensitivity / specificity %. IgM + IgG antibodies to Borrelia, including the round-body / persister form, in acute and chronic stages. TickPlex Plus adds 9 co-infections.
reactive T-cell detection — up to 200× the sensitivity of a traditional antibody assay*; quantitative reduction can be monitored every ~8 weeks as T-cell reactivity slows with effective therapy. *Lehmann PV et al., Handbook of ELISPOT, Springer 2012
two-colour readout separates active infection from immune memory — relapse insight from a single assay, across 17 pathogens.
intracellular immune-status marker — baseline before treatment, recovery signal at retest, from the same blood draw.
direct detection of 5 mycotoxins (aflatoxin B1, ochratoxin A, deoxynivalenol, fumonisin, zearalenone) for the mold-illness differential. Research-use-only assay.
Bartonella, Babesia, Ehrlichia/Anaplasma, Rickettsia, Chlamydia pneumoniae, Mycoplasma, Yersinia, EBV — each as a current-activity readout.

Every Jivora panel was custom-designed by Dr. Tichauer to reflect how vector-borne illness actually presents in practice — antibody serologies paired with the cellular assays that show current activity, per clinical pattern.
"Every person deserves clarity and accurate information about their health. My goal is to help you understand your test results and explore potential next steps with confidence."
Your patients get a complimentary educational review with Dr. Tichauer during open office hours after results arrive — a walkthrough of lab findings and immune-response data that keeps them engaged, informed, and back in your chair for the clinical decisions.
Lab-draw panels pair antibody serologies with the cellular assays that need venipuncture — the full clinical picture per pattern. Nine additional Tasso+ at-home panels (kit, shipping and return included) cover the antibody workups.
Tasso+ pricing includes kit, shipping and return. Cellular assays (EliSpot / iSpot) and immune-cell profiles require a venipuncture draw; antibody serologies collect by Tasso+. CPT codes on every requisition. Catalog v5 · Aug 2026.
Tasso+ is an FDA-cleared, virtually painless capillary device worn on the upper arm — about five minutes, no phlebotomy appointment, no no-shows.
Antibody serologies, TickPlex, foodscreens and parasite panels are Tasso+-eligible. EliSpot / iSpot and immune-cell profiles need a venipuncture draw (ACD/CPDA) — in your office or any draw site.
No. TickPlex is a modern multiplex immunoassay built on certified, third-party antigens, including the round-body antigen developed in the published research of Dr. Leona Gilbert (Tezted), not a lysate-derived antigen mix. Every positive and negative threshold is externally validated.
Neither. TickPlex runs at ~95% sensitivity and ~98% specificity in the same assay — defined antigens are paired with independently validated +/− thresholds. Controls run on every plate.
TickPlex: IgM + IgG to Borrelia plus the round-body / persister antigen. TickPlex Plus adds 9 co-infections, IgM + IgG each: 10 pathogen groups in one panel, each with its own validated threshold, reliable in acute and chronic stages.
EliSpot reads current T-cell activity at any stage — 1 reactive cell in 100,000 — and levels decrease ~4–8 weeks after effective therapy, making treatment trackable. iSpot's IFN-γ / IL-2 readout separates active infection from immune memory — relapse insight no serology offers.
Against third-party-validated +/− thresholds for every test — with controls on every run and annual independent assessment. Results arrive with per-marker commentary; the clinical team is available for case questions.
Sample stability is validated for transatlantic transit. Every kit ships with a prepaid, IATA-compliant mailer, RFID-tracked door-to-lab. Collect with FDA-cleared Tasso+ at home (~5 min) or a draw in your office.
Sign up, upload your license, countersign the BAA — your account is live within 1 business day. No contracts, no minimums. PHI is withheld on the server until both are verified, so compliance is built in, not bolted on.
Full ArminLabs catalog with transparent U.S. pricing before you order. The requisition builder pre-fills the member's recommended panel, handles draw addresses, and prints. Superbill support for reimbursement.
Tasso+ at home (~5 min) or a draw in your office. Prepaid IATA mail-back, RFID-tracked to Augsburg, and your dashboard follows every sample from "awaiting sample" to "results in" — results in 7–10 working days after receipt.
Your patients log daily symptoms and adherence — you see the trends they granted you, with flare monitoring, plateau flags and retest prompts. Priority alerts surface who needs attention before the next appointment.
Free account; license verification and BAA countersignature — active within 1 business day.
TickPlex, EliSpot, iSpot, CD57, ToxiPlex, co-infection panels — full catalog, prices upfront.
Home Tasso+ or in-office draw; prepaid IATA mailer, RFID-tracked to Augsburg.
7–10 working days after receipt, with per-marker commentary and retest reminders.
No. No contracts, no minimums — order when a case calls for it, at the same catalog pricing.
Antibody serologies, TickPlex, foodscreens and parasite panels are Tasso+-eligible. EliSpot / iSpot and immune-cell profiles need a venipuncture draw.
Certificates are downloadable in the accreditation section above; full assay documentation lives in the console.
Within 1 business day, with the full ArminLabs catalog available immediately.
The laboratory tests offered through Jivora Health are performed by ArminLabs | Medicum Bad Aibling MVZ GmbH, a CAP- and DAkkS-accredited, CLIA-certified laboratory that meets all applicable quality and regulatory standards for high-complexity testing. These laboratory-developed tests (LDTs) were designed and validated by ArminLabs and have not been cleared or approved by the U.S. Food and Drug Administration (FDA). The FDA does not currently require clearance or approval for LDTs performed in certified laboratories.
All test results are provided for informational and educational purposes only. They are not intended to diagnose, treat, cure, or prevent any disease and are not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with any questions you may have regarding your health. Review sessions with Jivora Health practitioners are educational in nature and do not constitute medical care.